Clinical Trial Update: A Study to Evaluate the Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate in Rwandan Healthcare Facilities [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial sponsored by Janssen evaluated sequential use of oral risperidone followed by paliperidone palmitate in Rwandan healthcare facilities; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• INVEGA SUSTENNA (PALIPERIDONE PALMITATE)
• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED